Trial NCT01202058

View at ClinicalTrials.gov 
Org. Study IDs: EC09-01

Last trial update was posted on 2012-10-25

MeSH Interventions

Everolimus Sirolimus

MeSH Conditions

Coronary Artery Disease Coronary Disease Myocardial Ischemia

Other Conditions

Atherosclerotic Coronary Artery Disease

Stopping Reasons

The NEVO™ stent will not be commercialized. Cordis decided to close the study after 1 years. This decision took the absence of safety signals into account.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID